Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Clinical Investigation · 2014-10 · 4 (10) · 935-950
DOI: 10.4155/cli.14.77 ↗At a glance
Journal article in Clinical Investigation, 2014-10. Written by Kouji Izumi and 2 co-authors. Institution: George Whipple Lab for Cancer Research, Departments of Pathology, Urology, & Radiation Oncology, The Wilmot Cancer Center, University of Rochester Me…. Cited 34 times so far (Crossref); 147 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS.
Abstract (original language)
Both benign prostatic hyperplasia (BPH) and prostate cancer (PCa) are frequent diseases in middle-aged to elderly men worldwide. While both diseases are linked to abnormal growth of the prostate, the epidemiological and pathological features of these two prostate diseases are different. BPH nodules typically arise from the transitional zone, and, in contrast, PCa arises from the peripheral zone. Androgen deprivation therapy alone may not be sufficient to cure these two prostatic diseases due to its undesirable side effects. The alteration of androgen receptor-mediated inflammatory signals from infiltrating immune cells and prostate stromal/epithelial cells may play key roles in those unwanted events. Herein, this review will focus on the roles of androgen/androgen receptor signals in the inflammation-induced progression of BPH and PCa.
Subjects
Author keywords
Authors and institutions
- George Whipple Lab for Cancer Research, Departments of Pathology, Urology, & Radiation Oncology, The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA ; Department of Integrative Can…
- George Whipple Lab for Cancer Research, Departments of Pathology, Urology, & Radiation Oncology, The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA.
- George Whipple Lab for Cancer Research, Departments of Pathology, Urology, & Radiation Oncology, The Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA ; Sex Hormone Research Center,…
Funding
- NCI NIH HHS
Cite
APA
Izumi, K., Li, L., & Chang, C. (2014). Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer. Clinical Investigation, 4(10), 935-950. https://doi.org/10.4155/cli.14.77
Vancouver
Izumi K, Li L, Chang C. Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer. Clinical Investigation. 2014;4(10):935-950. doi:10.4155/cli.14.77
BibTeX
@article{Izumi2014,
author = {Izumi, Kouji and Li, Lei and Chang, Chawnshang},
title = {Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer},
journal = {Clinical Investigation},
year = {2014},
volume = {4},
number = {10},
pages = {935--950},
doi = {10.4155/cli.14.77}
}
EUVIMED